S.S. Khan et al. / Tetrahedron 67 (2011) 1812e1820
1819
(CH2eCH2eCH3), 19.6 (CH2eCH3), 13.4 (CH3eCH2). HRMS (ESI): m/z
[MþH]þ calcd for C17H30N6O3: 367.2405; found: 367.2356.
ium) iodide (26). To a solution of the triazole 25 (0.35 g, 0.44 mmol)
in MeCN (10 mL), MeI (0.55 mL, 8.8 mmol, 20 equiv) was added.
The reaction mixture was refluxed under an argon atmosphere
overnight. After completion of the reaction, the solvent was re-
moved to obtain the product 26, which was purified by washing
with diethyl ether (3ꢀ10 mL). Brown-yellow oil, yield 90%. 1H NMR
4.6.10. 4,40-(3-(Prop-2-ynyloxy)propane-1,2-diyl)bis(oxy)bis(methy-
lene)bis(1-butyl-1H-1,2,3-triazole) (24). To a solution of 2,3-bis((1-
butyl-1H-1,2,3-triazol-4-yl)methoxy)propan-1-ol 23 (0.4 g, 1.1 mmol)
in anhydrous THF (10 mL) sodium hydride (0.042 g, 1.76 mmol) was
added. The suspension was stirred for 30 min and cooled with an ice
bath. With vigorous stirring propargyl bromide (0.16 mL, 1.76 mmol)
was added over 1 h, and the reaction mixture was stirred for 3 days at
room temperature. MeOH was added carefully until gas formation
ceased (destruction of excess sodium hydride). The solvent was re-
moved in vacuo and the residue was taken up in CH2Cl2 (5 mL) and
water (5 mL). After phase separation the organic phase was carefully
washed with water and dried with magnesium sulfate. The solvent was
removed and the raw product 24 was purified by column chroma-
tography (silica gel, 1:1 hexane/EtOAc and then only EtOAc, Rf¼0.10).
(CDCl3, 300 MHz):
d
(ppm)¼9.40 (s, 1H, CHtriazole), 9.32e9.33 (s, 2H,
CHtriazole), 7.24e7.30 (m, 10H, 2ꢀCHarom), 5.20e5.32 (m, 4H,
2ꢀCH2ePh), 5.04e5.11 (m, 4H, CHeC]OþCHeNtriazoleþCH2e
NeC]O), 4.97e5.02 (m, 2H, CH2eCtriazole), 4.58e4.63 (m, 4H,
2ꢀCH2eCtriazole), 4.38 (s, 3H, CH3eN), 4.35 (s, 3H, CH3eN), 4.23 (s,
3H, CH3eN), 4.14e4.19 (m, 4H, 2ꢀCH2eNtriazole), 3.93e4.08 (m, 5H,
OeCH2eCHeCH2eO), 3.09e3.14 (m, 1H, CH2eCHeC]O), 2.83e2.84
(m, 1H, CH2eCHeC]O), 1.92e1.98 (m, 4H, 2ꢀCH2eCH2eCH3),
1.30e1.42 (m, 4H, 2ꢀCH2eCH3), 0.89e0.94 (m, 6H, 2ꢀCH3eCH2).
13C NMR (CDCl3, 75 MHz):
d
(ppm)¼170.9 (CHeC]O), 153.6
(NeC]O), 141.3 (Ctriazole), 140.9 (Ctriazole), 138.3 (Carom), 128.6
(CHarom), 128.5 (CHarom), 128.4 (CHarom), 128.2 (CHarom), 128.1
(CHarom), 128.0 (CHarom), 78.2 (OeCH2eCHeCH2eO), 70.9
(OeCH2eCHeCH2eO), 67.6 (CH2ePh), 67.2 (CH2ePh), 62.0
(CH2eCtriazole), 61.2 (CH2eCtriazole), 57.6 (CHeC]O), 54.0
(CHeNtriazole), 51.3 (CH2eNtriazole), 51.2 (CH2eNeC]O), 40.3
(CH3eN), 40.2 (CH3eN), 40.1 (CH3eN), 35.5 (CH2eCHeC]O), 31.2
(CH2eCH2eCH3), 19.3 (CH2eCH3), 13.3 (CH3eCH2). HRMS (ESI): m/z
[M]3þ calcd for C43H61N10O37þ: 276.4901; found: 276.4854.
Colorless liquid, yield 51%.1H NMR (CDCl3, 300 MHz):
d
(ppm)¼7.59 (s,
1H, CHtriazole), 7.55 (s, 1H, CHtriazole), 4.77 (s, 2H, CH2eCtriazole), 4.63 (s,
2H, CH2eCtriazole), 4.27e4.34 (m, 4H, 2ꢀCH2eNtriazole), 4.12e4.13 (m,
2H, CH2eC^CH), 3.79 (m, 1H, CH2eCHeCH2), 3.60e3.63 (m, 4H,
CH2eCHeCH2), 2.39e2.41 (m, 1H, CH2eC^CH), 1.81e1.85 (m, 4H,
2ꢀCH2eCH2eCH3),1.28e1.36 (m, 4H, 2ꢀCH2eCH3), 0.89e0.94 (m, 6H,
2ꢀCH3eCH2). 13C NMR (CDCl3, 75 MHz):
d
(ppm)¼145.3 (Ctriazole),
144.9 (Ctriazole),122.5 (CHtriazole),122.3 (CHtriazole), 79.5 (CH2eCHeCH2),
74.6
(CH2eCHeCH2eOeCH2eC^CH),
70.2
(C^CH),
69.6
(CH2eOeCH2eC^CH), 64.9 (CH2eCtriazole), 63.8 (CH2eCtriazole), 58.5
(CH2eC^CH), 50.0 (CH2eNtriazole), 32.2 (CH2eCH2eCH3), 19.6
(CH2eCH3), 13.4 (CH3eCH2). HRMS (ESI): m/z [MþH]þ calcd for
C20H32N6O3: 405.2501; found: 405.2459.
4.6.13. 5,50-(3-((1-((3S,5S)-5-Carboxypyrrolidin-3-yl)-3-methyl-1H-
1,2,3-triazol-3-ium-4-yl)methoxy)propane-1,2-diyl)-bis-(oxy)-bis-
(methylene)-bis-(3-butyl-1-methyl-3H-1,2,3-triazol-1-ium)
tetra-
fluoroborate (7d). In a 50 mL dry, round-bottom flask triazolium
iodide 26 (0.4 g, 0.33 mmol) was dissolved in anhydrous MeOH
(15 mL). In a second flask (which was either brown colored or
wrapped in aluminum foil to exclude light), AgBF4 (0.32 g,
1.65 mmol, 5 equiv) was dissolved in anhydrous MeOH (20 mL). The
AgBF4 solutionwas added dropwise to the solution of iodide 26 until
no more precipitate (AgI) was formed. After the precipitate had
settled down, the clear supernatant solution was separated, dried,
andevaporated giving a quantitativeyield of the tetrafluoroborate as
yellow oil. To a solution of this tetrafluoroborate (0.35 g, 0.32 mmol)
in anhydrous MeOH (5 mL), Pd/C (40 mg) was added and the mix-
ture was pressurized under H2 at 5 bar. After stirring overnight, the
Pd/C was filtered off and the filtratewas concentrated under vacuum
to give desire product 7d.
4.6.11. (2S,4S)-Dibenzyl 4-(4-((2,3-bis((1-butyl-1H-1,2,3-triazol-4-
yl)methoxy)propoxy)methyl)-1H-1,2,3-triazol-1-yl)pyrrolidine-1,2-
dicarboxylate (25). To a solution of azide 16 (0.19 g, 0.5 mmol) in
MeOH (5 mL) sodium ascorbate (0.02 g, 20 mol %), CuSO4 (0.012 g,
15 mol %), and alkyne 24 (0.2 g, 0.5 mmol) were added. The solution
was stirred at room temperature for 2e3 days (TLC check). After
completion of the reaction, water (10 mL) was added and the mix-
ture was extracted with ethyl acetate (3ꢀ10 mL). The combined or-
ganic layers were washed with brine (10 mL) and then dried over
Na2SO4. Evaporation of the solvent in vacuo gave 25 as colorless
liquid that was used in the next step without further purification.
Light yellow oil, yield 95%. 1H NMR (CDCl3, 300 MHz):
d
(ppm)¼7.76
(s, 1H, CHtriazole), 7.64 (s, 1H, CHtriazole), 7.59 (s, 1H, CHtriazole),
7.30e7.35 (m, 10H, 2ꢀCHarom), 5.08e5.26 (m, 4H, 2ꢀCH2ePh),
4.95e5.06 (m, 2H, CHeC]OþCHeNtriazole), 4.78 (s, 2H, CH2eCtria-
zole), 4.60e4.63 (m, 4H, 2ꢀCH2eCtriazole), 4.29e4.36 (m, 4H,
2ꢀCH2eNtriazole), 3.94e3.97 (m, 1H, OeCH2eCHeCH2eO),
3.76e3.82 (m, 2H, CH2eNeC]O), 3.60e3.64 (m, 4H,
OeCH2eCHeCH2eO), 2.91e2.96 (m,1H, CH2eCHeC]O), 2.64e2.78
(m, 1H, CH2eCHeC]O), 1.81e1.93 (m, 4H, 2ꢀCH2eCH2eCH3),
Colorless oil, yield 94%. 1H NMR (CD3OD, 300 MHz):
8.70 (s, 1H, CHtriazole), 8.59 (s, 1H, CHtriazole), 8.58 (s, 1H, CHtriazole),
4.88e4.90 (m, 8H,
d
(ppm)¼
CHeC]OþCHeNtriazoleþCH2eNeC]
Oþ2ꢀCH2eCtriazole), 4.86 (s, 2H, CH2eCtriazole), 4.28 (s, 3H, CH3eN),
4.27 (s, 3H, CH3eN), 4.26 (s, 3H, CH3eN), 4.58e4.62 (m, 4H,
2ꢀCH2eNtriazole), 4.01e4.05 (m, 2H, OeCH2eCHeCH2eO), 3.80 (m,
3H, OeCH2eCHeCH2eO), 3.31e3.36 (m, 2H, CH2eCHeC]O),
1.97e2.02 (m, 4H, 2ꢀCH2eCH2eCH3), 1.38e1.44 (m, 4H,
2ꢀCH2eCH3), 0.97e1.02 (m, 6H, 2ꢀCH3eCH2). 13C NMR (CD3OD,
1.30e1.40 (m, 4H, 2ꢀCH2eCH3), 0.91e0.97 (m, 6H, 2ꢀCH3eCH2). 13
C
NMR (CDCl3, 75 MHz):
d
(ppm)¼171.1 (CHeC]O), 154.4 (NeC]O),
75 MHz):
d
(ppm)¼141.3 (Ctriazole), 141.0 (Ctriazole), 140.6 (Ctriazole),
145.5 (Ctriazole), 136.0 (Carom), 128.6 (CHarom), 128.6 (CHarom), 128.2
(CHarom), 128.1 (CHarom), 128.0 (CHarom), 127.9 (CHarom), 121.9
(CHtriazole),
(OeCH2eCHeCH2eO), 70.2 (OeCH2eCHeCH2eO), 67.5 (CH2ePh),
67.3 (CH2ePh), 64.7 (CH2eCtriazole), 63.8 (CH2eCtriazole), 60.4
(CH2eCtriazole), 57.9 (CHeC]O), 57.6 (CHeNtriazole), 50.1 (CH2eNtria-
129.6 (CHtriazole), 129.0 (CHtriazole), 128.9 (CHtriazole), 78.1
(OeCH2eCHeCH2eO), 70.5 (OeCH2eCHeCH2eO), 70.4 (OeCH2e
CHeCH2eO), 61.8 (CH2eCtriazole), 60.5 (CH2eCtriazole), 59.7
(CH2eCtriazole), 58.7 (CHeC]O), 53.2 (CHeNtriazole), 50.0
(CH2eNtriazole), 47.2 (CH2eNeC]O), 37.8 (CH3eN), 37.4 (CH3eN),
37.3 (CH3eN), 33.3 (CH2eCHeC]O), 30.7 (CH2eCH2eCH3), 18.9
(CH2eCH3), 12.2 (CH3eCH2). HRMS (ESI): m/z [M]3þ calcd for
C28H49N10O35þ: 201.7966; found: 201.7917.
121.9
(CHtriazole),
121.8
(CHtriazole),
77.2
zole),
50.0
(CH2eNeC]O),
35.1
(CH2eCHeC]O),
32.2
(CH2eCH2eCH3), 19.7 (CH2eCH3), 13.5 (CH3eCH2). HRMS (ESI): m/z
[MþH]þ calcd for C40H52N10O7: 785.4001; found: 785.3981.
Acknowledgements
4.6.12. 5,50-(3-((1-((3S,5S)-1,5-Bis(benzyloxycarbonyl)pyrrolidin-3-
yl)-3-methyl-1H-1,2,3-triazol-3-ium-4-yl)methoxy)propane-1,2-diyl)
bis(oxy)bis(methylene)-bis-(3-butyl-1-methyl-3H-1,2,3-triazol-1-
We gratefully acknowledge financial support by Deutsche For-
schungsgemeinschaft (DFG). Priority Programme Organocatalysis